Proteomics profiling reveals signaling pathways associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathy

Lee, C., Liang, L. W., Hasegawa, K., Maurer, M. S., Tower-Rader, A., Fifer, M. A., Reilly, M. P., & Shimada, Y. J. (2022). Proteomics profiling reveals signaling pathways associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathy. European Heart Journal, 43(Supplement_2). https://doi.org/10.1093/eurheartj/ehac544.1724
Authors:
C Lee
Lusha W. Liang
Kiyozo Hasegawa
Matthew J. Maurer
Albree Tower‐Rader
Michael A. Fifer
Muredach P. Reilly
Yuichi J. Shimada
Affiliated Authors:
C Lee
Lusha W. Liang
Matthew J. Maurer
Muredach P. Reilly
Yuichi J. Shimada
Columbia Affiliation:
Subjects:
Diagnosis and Management of Hypertrophic Cardiomyopathy (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1093/eurheartj/ehac544.1724
DOI:
10.1093/eurheartj/ehac544.1724
Journal:
European Heart Journal
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: